Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
AEG-1 regulates retinoid X receptor and inhibits retinoid signaling
Jyoti Srivastava1, Chadia L Robertson2, Devaraja Rajasekaran1
1Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia.
Abstract:
Retinoid X receptor (RXR) regulates key cellular responses such as cell growth and development, and this regulation is frequently perturbed in various malignancies, including hepatocellular carcinoma (HCC). However, the molecule(s) that physically govern this deregulation are mostly unknown. Here, we identified RXR as an interacting partner of astrocyte-elevated gene-1 (AEG-1)/metadherin (MTDH), an oncogene upregulated in all cancers. Upon interaction, AEG-1 profoundly inhibited RXR/retinoic acid receptor (RAR)-mediated transcriptional activation. Consequently, AEG-1 markedly protected HCC and acute myelogenous leukemia (AML) cells from retinoid- and rexinoid-induced cell death. In nontumorigenic cells and primary hepatocytes, AEG-1/RXR colocalizes in the nucleus in which AEG-1 interferes with recruitment of transcriptional coactivators to RXR, preventing transcription of target genes. In tumor cells and AEG-1 transgenic hepatocytes, overexpressed AEG-1 entraps RXR in cytoplasm, precluding its nuclear translocation. In addition, ERK, activated by AEG-1, phosphorylates RXR that leads to its functional inactivation and attenuation of ligand-dependent transactivation. In nude mice models, combination of all-trans retinoic acid (ATRA) and AEG-1 knockdown synergistically inhibited growth of human HCC xenografts. The present study establishes AEG-1 as a novel homeostatic regulator of RXR and RXR/RAR that might contribute to hepatocarcinogenesis. Targeting AEG-1 could sensitize patients with HCC and AML to retinoid- and rexinoid-based therapeutics.
Insights
Astrocyte-elevated gene-1 (AEG-1) interacts with Retinoid X receptor (RXR), inhibiting its function and promoting cancer cell survival. Targeting AEG-1 may enhance cancer therapy effectiveness.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Biology
Background:
- Retinoid X receptor (RXR) plays a crucial role in cell growth and development, but its regulation is often disrupted in cancers like hepatocellular carcinoma (HCC).
- The specific molecules responsible for RXR deregulation in cancer remain largely unidentified.
Purpose of the Study:
- To identify molecules that interact with and regulate RXR function in cancer.
- To investigate the role of astrocyte-elevated gene-1 (AEG-1) in RXR deregulation and its impact on cancer cell survival and proliferation.
Main Methods:
- Identified RXR as an interacting partner of AEG-1 using co-immunoprecipitation and Western blotting.
- Assessed the effect of AEG-1 on RXR/retinoic acid receptor (RAR)-mediated transcriptional activation using reporter gene assays.
- Examined the subcellular localization of RXR and AEG-1 in different cell types via immunofluorescence microscopy.
- Investigated the role of ERK signaling in AEG-1-mediated RXR phosphorylation using Western blotting and kinase assays.
- Evaluated the therapeutic potential of combining all-trans retinoic acid (ATRA) with AEG-1 knockdown in a human HCC xenograft mouse model.
Main Results:
- AEG-1 directly interacts with RXR and inhibits RXR/RAR-mediated transcription.
- AEG-1 confers resistance to retinoid- and rexinoid-induced cell death in HCC and acute myelogenous leukemia (AML) cells.
- AEG-1 alters RXR localization (cytoplasmic entrapment in tumor cells) and promotes RXR phosphorylation by ERK, leading to functional inactivation.
- Combined ATRA treatment and AEG-1 knockdown synergistically inhibited HCC xenograft growth in vivo.
Conclusions:
- AEG-1 is a novel regulator of RXR and RXR/RAR activity, contributing to hepatocarcinogenesis.
- AEG-1-mediated RXR inhibition represents a potential therapeutic vulnerability in HCC and AML.
- Targeting AEG-1 could sensitize cancer patients to retinoid- and rexinoid-based therapies.
More Related Videos
08:18Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
Published on: October 4, 2024
09:07Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Negative Regulator Molecules